Catalyst Wire Dossier Catalyst Wire Dossier

KEPPRA XR

levetiracetam · UCB, Inc.
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for KEPPRA XR, covering 2008-09-12 to 2024-03-12. Get the full timeline:

Most recent: FDA Approved: KEPPRA XR — Supplemental Application (UCB, Inc.)

See pricing